About Careers MedBlog Contact us

UCLA Develops New Method for Creating Optimal Drug Combinations

by Vishnuprasad on February 26, 2015 at 8:18 PM
Font : A-A+

 UCLA Develops New Method for Creating Optimal Drug Combinations

Scientists at UCLA have developed a new technique for creating patient specific combination drug regimens that, at least in laboratory tests, have shown more effective than existing techniques.

Moreover, to make the drug therapy even more powerful, the research team used nanodiamonds in helping to deliver drugs to neoplastic cells.


The so-called Feedback System Control.II uses phenotypic information in evaluating the effectiveness of a particular drug combination. Once the optimal combo therapy has been identified, the drugs are assembled along with nanodiamonds attached to their surface.

The compounds were introduced to cancer cell lines and the nanodiamonds acted as anchors that prevented the drugs from being excreted by the cancer cells. This allowed the drug therapy to act for longer periods of time, getting the most out of each drug payload without harming as many healthy cells nearby.

Combination therapy, particularly in cancer treatment, is a common way of attacking aggressive diseases, but they often miss their targets.

"This optimized nanodrug combination approach can be used for virtually every type of disease model and is certainly not limited to cancer. Additionally, this study shows that we can design optimized combinations for virtually every type of drug and any type of nanotherapy," said Dr. Chih-Ming Ho, a professor of mechanical engineering at UCLA.

Source: Medindia


Recommended Reading

Latest Cancer News

Why Is Time of Day Important in Cancer Diagnosis and Treatment?
Chronotherapy (the sleep-wake cycle) is observed as a valuable alternative treatment in cancer diagnosis and treatment.
How Do Neutrophils Impact Pancreatic Cancer Treatment Resistance?
A nanoengineering platform targets neutrophils, the white blood cells without killing pancreatic cancer cells paving the way for effective treatments.
Lung Cancer: The Survival Advantage of Lobectomy Over Wedge Resection
The survival rates between lobectomy and wedge resection surgical procedures were found to be the same among lung cancer patients.
Could TKI Cancer Drugs Lead to Inflammatory Side Effects?
The mechanism by which the kinases cause inflammation has been discovered by scientists.
Are Biomarkers the Key to Identifying Early Pancreatic Risk?
Pancreatic cancer cases are on the rise. The biomarker approach could reduce the chance of developing pancreatic cancer.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close

UCLA Develops New Method for Creating Optimal Drug Combinations Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests